Mirum Pharmaceuticals Stock Price Patterns
| MIRM Stock | USD 103.22 0.30 0.29% |
Momentum 72
Buy Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.12) | EPS Estimate Current Year (0.27) | EPS Estimate Next Year 0.02 | Wall Street Target Price 114.7 | EPS Estimate Current Quarter (0.16) |
Using Mirum Pharmaceuticals hype-based prediction, you can estimate the value of Mirum Pharmaceuticals from the perspective of Mirum Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Mirum Pharmaceuticals using Mirum Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Mirum using crowd psychology based on the activity and movement of Mirum Pharmaceuticals' stock price.
Mirum Pharmaceuticals Short Interest
An investor who is long Mirum Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Mirum Pharmaceuticals and may potentially protect profits, hedge Mirum Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 64.1054 | Short Percent 0.1469 | Short Ratio 8.41 | Shares Short Prior Month 8.4 M | 50 Day MA 79.4537 |
Mirum Pharmaceuticals Hype to Price Pattern
Investor biases related to Mirum Pharmaceuticals' public news can be used to forecast risks associated with an investment in Mirum. The trend in average sentiment can be used to explain how an investor holding Mirum can time the market purely based on public headlines and social activities around Mirum Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Mirum Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Mirum Pharmaceuticals.
Mirum Pharmaceuticals Implied Volatility | 0.63 |
Mirum Pharmaceuticals' implied volatility exposes the market's sentiment of Mirum Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Mirum Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Mirum Pharmaceuticals stock will not fluctuate a lot when Mirum Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Mirum Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Mirum because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Mirum Pharmaceuticals after-hype prediction price | USD 103.22 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Mirum contract
Based on the Rule 16, the options market is currently suggesting that Mirum Pharmaceuticals will have an average daily up or down price movement of about 0.0394% per day over the life of the 2026-04-17 option contract. With Mirum Pharmaceuticals trading at USD 103.22, that is roughly USD 0.0406 . If you think that the market is fully incorporating Mirum Pharmaceuticals' daily price movement you should consider acquiring Mirum Pharmaceuticals options at the current volatility level of 0.63%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Mirum Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Mirum Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Mirum Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Mirum Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Mirum Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Mirum Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Mirum Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Mirum Pharmaceuticals' historical news coverage. Mirum Pharmaceuticals' after-hype downside and upside margins for the prediction period are 100.57 and 105.87, respectively. We have considered Mirum Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Mirum Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Mirum Pharmaceuticals is based on 3 months time horizon.
Mirum Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Mirum Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mirum Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Mirum Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.65 | 2.67 | 0.14 | 0.97 | 5 Events / Month | 7 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
103.22 | 103.22 | 0.00 |
|
Mirum Pharmaceuticals Hype Timeline
Mirum Pharmaceuticals is now traded for 103.22. The entity has historical hype elasticity of 0.14, and average elasticity to hype of competition of -0.97. Mirum is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at 0.65%. %. The volatility of related hype on Mirum Pharmaceuticals is about 178.83%, with the expected price after the next announcement by competition of 102.25. About 98.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.85. Mirum Pharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 5 days. Check out Mirum Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Mirum Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Mirum Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Mirum Pharmaceuticals' future price movements. Getting to know how Mirum Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Mirum Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BLTE | Belite Bio ADR | (8.93) | 8 per month | 2.65 | 0.23 | 7.96 | (5.94) | 18.84 | |
| SLNO | Soleno Therapeutics | 0.95 | 9 per month | 0.00 | (0.17) | 5.16 | (4.91) | 28.47 | |
| LGND | Ligand Pharmaceuticals Incorporated | (0.84) | 8 per month | 2.08 | (0.0001) | 3.51 | (2.76) | 18.09 | |
| ADMA | ADMA Biologics | 0.13 | 8 per month | 2.62 | 0.05 | 5.01 | (4.27) | 13.78 | |
| PRAX | Praxis Precision Medicines | (7.26) | 8 per month | 3.90 | 0.15 | 9.33 | (6.06) | 36.21 | |
| ACAD | ACADIA Pharmaceuticals | 0.44 | 10 per month | 1.51 | 0.06 | 3.31 | (2.46) | 9.79 | |
| DYN | Dyne Therapeutics | 0.21 | 5 per month | 0.00 | (0.09) | 7.01 | (5.90) | 26.40 | |
| TVTX | Travere Therapeutics | 0.21 | 5 per month | 3.49 | 0.03 | 5.77 | (5.47) | 33.22 | |
| RARE | Ultragenyx | 0.21 | 2 per month | 0.00 | (0.06) | 7.73 | (4.09) | 51.23 | |
| TLX | Telix Pharmaceuticals Limited | (0.05) | 9 per month | 0.00 | (0.22) | 4.24 | (5.43) | 13.60 |
Mirum Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Mirum price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Mirum using various technical indicators. When you analyze Mirum charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Mirum Pharmaceuticals Predictive Indicators
The successful prediction of Mirum Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Mirum Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Mirum Pharmaceuticals based on analysis of Mirum Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Mirum Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Mirum Pharmaceuticals's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 6.34 | 5.59 | 5.03 | 5.28 | Days Of Inventory On Hand | 173.13 | 100.16 | 115.18 | 200.1 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Mirum Pharmaceuticals Basic Forecasting Models to cross-verify your projections. To learn how to invest in Mirum Stock, please use our How to Invest in Mirum Pharmaceuticals guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Will Biotechnology sector continue expanding? Could Mirum diversify its offerings? Factors like these will boost the valuation of Mirum Pharmaceuticals. Expected growth trajectory for Mirum significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mirum Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.85) | Revenue Per Share | Quarterly Revenue Growth 0.472 | Return On Assets | Return On Equity |
Understanding Mirum Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Mirum's accounting equity. The concept of intrinsic value—what Mirum Pharmaceuticals' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Mirum Pharmaceuticals' price substantially above or below its fundamental value.
Understanding that Mirum Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mirum Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Mirum Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.